References
- Gefter WB, Weingrad TR, Epstein DM, Ochs RH, Miller WT. �Semi-invasive� pulmonary aspergillosis. Radiology 1981; 140: 313–321.
- Binder RE, Faling LJ, Pugatch RD, Mahasaen C, Snider GL. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982; 61: 109–124.
- NavarroM, Domingo C, Gallego M, et al . Aspergilosis pulmonar necrosante cro�nica: una forma infrecuente de infeccio�n por Aspergillus. Enferm Infecc Microbiol Clin 1998; 16: 175–178.
- Kato T, Usami I, Morita H, et al . Chronic necrotizing pulmonary aspergillosis in pneumoconiosis: clinical and radiologic findings in 10 patients. Chest 2002; 12: 118–127.
- Saraceno JL, Phelps DT, Ferro TJ, Futerfas R, Schwartz DB. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 1997; 112: 541–548.
- Caras WE, Pluss JL. Chronic necrotizing pulmonary aspergillosis: pathologic outcome after itraconazole therapy. Mayo Clin Proc 1996; 71: 25–30.
- Are�valo M, Solera J, Rodriguez F, Vizcaya M, Vercher R, Martinez-Moratalla J. Aspergilosis pulmonar necrosante cro�nica por Aspergillus niger. Med Clin (Barc) 1991; 97: 620–622.
- Espinel-Ingroff A, Rezusta A. E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J Clin Microbiol 2002; 40: 2101–2107.
- Herbrecht R, Denning DW, Patterson TF, et al . Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–415.
- Rubin MA, Carroll KC, Cahill BC. Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans. Clin Infect Dis 2002; 34: 1160–1161.